151 related articles for article (PubMed ID: 37434173)
21. Retraction Note: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo.
Qi ZY; Wang F; Yue YY; Guo XW; Guo RM; Li HL; Xu YY
J Ovarian Res; 2023 Aug; 16(1):174. PubMed ID: 37626400
[No Abstract] [Full Text] [Related]
22. Editorial: Novel targets for ovarian cancer stem cells.
Wang Y; Sima LE; Jia D; Zhao G; Zhang Y; Xie J
Front Oncol; 2023; 13():1325066. PubMed ID: 38023161
[No Abstract] [Full Text] [Related]
23. A risk score combining co-expression modules related to myeloid cells and alternative splicing associates with response to PD-1/PD-L1 blockade in non-small cell lung cancer.
Han Y; Liu SM; Jin R; Meng W; Wu YL; Li H
Front Immunol; 2023; 14():1178193. PubMed ID: 37492578
[TBL] [Abstract][Full Text] [Related]
24. Targeting LSD1 in tumor immunotherapy: rationale, challenges and potential.
Bao L; Zhu P; Mou Y; Song Y; Qin Y
Front Immunol; 2023; 14():1214675. PubMed ID: 37483603
[TBL] [Abstract][Full Text] [Related]
25. Effective Treatment for Recurrent Ovarian Cancer Guided by Drug Sensitivity from Ascites-Derived Organoid: A Case Report.
Chen W; Fang PH; Zheng B; Liang Y; Mao Y; Jiang X; Tang Q
Int J Womens Health; 2023; 15():1047-1057. PubMed ID: 37465723
[TBL] [Abstract][Full Text] [Related]
26. A novel metabolic subtype with S100A7 high expression represents poor prognosis and immuno-suppressive tumor microenvironment in bladder cancer.
Cai Y; Cheng Y; Wang Z; Li L; Qian Z; Xia W; Yu W
BMC Cancer; 2023 Aug; 23(1):725. PubMed ID: 37543645
[TBL] [Abstract][Full Text] [Related]
27. Pathogenesis of cancers derived from thyroid follicular cells.
Fagin JA; Krishnamoorthy GP; Landa I
Nat Rev Cancer; 2023 Sep; 23(9):631-650. PubMed ID: 37438605
[TBL] [Abstract][Full Text] [Related]
28. Identification of mitochondrial related signature associated with immune microenvironment in Alzheimer's disease.
Zhang Y; Miao Y; Tan J; Chen F; Lei P; Zhang Q
J Transl Med; 2023 Jul; 21(1):458. PubMed ID: 37434203
[TBL] [Abstract][Full Text] [Related]
29. Exploring the cellular and molecular differences between ovarian clear cell carcinoma and high-grade serous carcinoma using single-cell RNA sequencing and GEO gene expression signatures.
Guo D; Zhang S; Gao Y; Shi J; Wang X; Zhang Z; Zhang Y; Wang Y; Zhao K; Li M; Wang A; Wang P; Gou Y; Zhang M; Liu M; Zhang Y; Chen R; Sun J; Wang S; Wu X; Liang Z; Chen J; Lang J
Cell Biosci; 2023 Jul; 13(1):139. PubMed ID: 37525249
[TBL] [Abstract][Full Text] [Related]
30. LSD1: an emerging face in altering the tumor microenvironment and enhancing immune checkpoint therapy.
Mamun MAA; Zhang Y; Zhao JY; Shen DD; Guo T; Zheng YC; Zhao LJ; Liu HM
J Biomed Sci; 2023 Jul; 30(1):60. PubMed ID: 37525190
[TBL] [Abstract][Full Text] [Related]
31. Recent advances of exosomal circRNAs in cancer and their potential clinical applications.
Yi Q; Yue J; Liu Y; Shi H; Sun W; Feng J; Sun W
J Transl Med; 2023 Jul; 21(1):516. PubMed ID: 37525158
[TBL] [Abstract][Full Text] [Related]
32. Ferroptosis in tumors and its relationship to other programmed cell death: role of non-coding RNAs.
Zhang Q; Fan X; Zhang X; Ju S
J Transl Med; 2023 Jul; 21(1):514. PubMed ID: 37516888
[TBL] [Abstract][Full Text] [Related]
33. Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression.
Kotsari M; Dimopoulou V; Koskinas J; Armakolas A
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511228
[TBL] [Abstract][Full Text] [Related]
34. Radiomics using computed tomography to predict CD73 expression and prognosis of colorectal cancer liver metastases.
Saber R; Henault D; Messaoudi N; Rebolledo R; Montagnon E; Soucy G; Stagg J; Tang A; Turcotte S; Kadoury S
J Transl Med; 2023 Jul; 21(1):507. PubMed ID: 37501197
[TBL] [Abstract][Full Text] [Related]
35. Identification of pyroptosis-related genes and potential drugs in diabetic nephropathy.
Yan M; Li W; Wei R; Li S; Liu Y; Huang Y; Zhang Y; Lu Z; Lu Q
J Transl Med; 2023 Jul; 21(1):490. PubMed ID: 37480090
[TBL] [Abstract][Full Text] [Related]
36. Single-cell analysis of white adipose tissue reveals the tumor-promoting adipocyte subtypes.
Liu SQ; Chen DY; Li B; Gao ZJ; Feng HF; Yu X; Liu Z; Wang Y; Li WG; Sun S; Sun SR; Wu Q
J Transl Med; 2023 Jul; 21(1):470. PubMed ID: 37454080
[TBL] [Abstract][Full Text] [Related]
37. Infiltration of a Unique CD8
Zhang Y; Cui K; Yang Y; Liu B; Zhu M; Chen H; Zhao C; Zhou Y; Nie Y
J Hepatocell Carcinoma; 2023; 10():1051-1067. PubMed ID: 37449280
[TBL] [Abstract][Full Text] [Related]
38. Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical Validation.
Willing EM; Vollbrecht C; Vössing C; Weist P; Schallenberg S; Herbst JM; Schatz S; Jóri B; Bataillon G; Harter P; Salutari V; Martin AG; Vergote I; Colombo N; Roeper J; Berg T; Berger R; Kah B; Noettrup TJ; Falk M; Arndt K; Polten A; Ray-Coquard I; Selzam F; Pirngruber J; Schmidt S; Hummel M; Tiemann M; Horst D; Sehouli J; Pujade-Lauraine E; Tiemann K; Braicu EI; Heukamp LC
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444554
[TBL] [Abstract][Full Text] [Related]
39. A precise molecular subtyping of ulcerative colitis reveals the immune heterogeneity and predicts clinical drug responses.
Mo S; Jin B; Tseng Y; Lin L; Lin L; Shen X; Song H; Kong M; Luo Z; Chu Y; Jiang C; Cao Z; Liu J; Luo F
J Transl Med; 2023 Jul; 21(1):466. PubMed ID: 37443022
[TBL] [Abstract][Full Text] [Related]
40. Spatially resolved transcriptomic profiles reveal unique defining molecular features of infiltrative 5ALA-metabolizing cells associated with glioblastoma recurrence.
Andrieux G; Das T; Griffin M; Straehle J; Paine SML; Beck J; Boerries M; Heiland DH; Smith SJ; Rahman R; Chakraborty S
Genome Med; 2023 Jul; 15(1):48. PubMed ID: 37434262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
